Literature DB >> 31556690

Trial of Essential Oils to Improve Sleep for Patients in Cardiac Rehabilitation.

Brenda McDonnell1, Patricia Newcomb2.   

Abstract

Objectives: The objective of this study was to determine if there was a significant difference between the sleep quality of patients who inhaled placebo and those who inhaled an aroma comprising a mixture of Lavandula x intermedia (Lavandin Super), Citrus bergamia (bergamot), and Cananga odorata (ylang ylang). Design: This was a randomized, double-blind crossover study, which compared a treatment with placebo. Settings/location: The study was conducted in an outpatient cardiac rehabilitation unit located in an urban, private nonprofit hospital in north Texas. Subjects: Participants included 42 adult patients referred to the rehabilitation service following hospitalizations by local cardiologists. Interventions: Cotton balls infused with a combination of lavender, bergamot, and ylang ylang or placebo were placed at subjects' bedsides for five nights. After a washout period, subjects crossed over to the other condition for five nights. Outcome measures: Participants completed the Pittsburgh Sleep Quality Index (PSQI) after treatment and placebo periods. Lower PSQI scores indicate better sleep quality.
Results: The mean PSQI global score was statistically significantly lower when receiving the intervention oil (mean = 4.9) than the mean PSQI global score when receiving placebo (mean = 8). Duration of sleep and the time it took to fall asleep were no different between treatment groups, but patient-reported sleep quality was significantly better when participants were exposed to essential oils (χ2 = 4.5, p = 0.03) than when exposed to placebo. Although sleep efficiency (time asleep while lying in bed) was perceived as the same under both conditions, participants reported that they had to get up to use the bathroom significantly less often when exposed to the treatment than when exposed to placebo (t = -2.04, p = 0.05; Wilcoxon p = 0.05). Participants also reported that they had trouble sleeping because they felt too cold, which occurred significantly less often when exposed to the treatment than when exposed to placebo (t = -2.03, p = 0.05; Wilcoxon p = 0.05). Conclusions: Sleep quality of participants receiving intervention oils was significantly better than the sleep quality of participants receiving the placebo oil. Low-cost, nontraditional aromatherapy treatment is potentially effective for improving sleep quality among cardiac rehabilitation patients.

Entities:  

Keywords:  bergamot; cardiac rehabilitation; essential oils; lavender; sleep; ylang ylang

Year:  2019        PMID: 31556690     DOI: 10.1089/acm.2019.0222

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  4 in total

1.  Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia.

Authors:  Damiana Scuteri; Giorgio Sandrini; Stefano Tamburin; Maria Tiziana Corasaniti; Pierluigi Nicotera; Paolo Tonin; Giacinto Bagetta
Journal:  Phytother Res       Date:  2021-08-26       Impact factor: 6.388

2.  Correlation between Sleep Time, Sleep Quality, and Emotional and Cognitive Function in the Elderly.

Authors:  Heng Liao; Sha Liao; Yu-Jiao Gao; Jing-Ping Mu; Xi Wang; De-Sen Chen
Journal:  Biomed Res Int       Date:  2022-05-14       Impact factor: 3.246

3.  Effect of Sleep Intervention Programs during Cardiac Rehabilitation on the Sleep Quality of Heart Patients.

Authors:  Fatemeh Ghane; Mahdieh Ghanbari Firoozabadi; Farzan Madadizadeh; Khadijeh Nasiriani
Journal:  Sleep Disord       Date:  2022-03-24

4.  Role of 5-HT1A Receptor in the Anxiolytic-Relaxant Effects of Bergamot Essential Oil in Rodent.

Authors:  Laura Rombolà; Damiana Scuteri; Chizuko Watanabe; Shinobu Sakurada; Kengo Hamamura; Tsukasa Sakurada; Paolo Tonin; Maria Tiziana Corasaniti; Giacinto Bagetta; Luigi Antonio Morrone
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.